ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 986,65
0,37%
Dow Jones
38 785,20
0,28%
DAX
18 112,43
0,66%
Brent Oil
83,495
0,45%
Bitcoin
63 849,24
-0,23%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. MiroMatrix Medical Inc (MIRO)

  7. MiroMatrix Medical Inc (MIRO) Actualités

MIRO MiroMatrix Medical Inc

3,39
0,00 (0,00%)
Dernière mise à jour : 02:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
MiroMatrix Medical Inc MIRO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 3,39 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,39
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
26/12/202312:02EDGAR2Form 15-12G - Securities registration termination [Section..
18/12/202322:30EDGAR2Form 8-K - Current report
18/12/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
13/12/202322:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202316:14EDGAR2Form POS AM - Post-Effective amendments for registration..
13/12/202316:13EDGAR2Form S-8 POS - Securities to be offered to employees in..
13/12/202316:03EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
13/12/202315:15BWUnited Therapeutics and Miromatrix Medical Announce..
12/12/202317:22EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
12/12/202312:00BWUnited Therapeutics and Miromatrix Medical Announce..
07/12/202322:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
30/11/202323:14EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
14/11/202322:05GLOBEMiromatrix Reports Third Quarter 2023 Results
14/11/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202313:01EDGAR2Form SC 14D9 - Solicitation, recommendation statements
30/10/202312:03EDGAR2Form SC14D9C - Written communication relating to third party..
30/10/202311:12EDGAR2Form 8-K - Current report
30/10/202311:05GLOBEUnited Therapeutics to Acquire Miromatrix Medical
30/10/202311:00BWUnited Therapeutics to Acquire Miromatrix Medical
11/10/202322:05GLOBEMiromatrix to Present at the 2023 ISODP Organ Donation..
05/10/202322:30GLOBEMiromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene..
06/9/202322:01GLOBEMiromatrix Announces Participation in H.C. Wainwright Global..
05/9/202322:04GLOBEMiromatrix Announces Participation in the ARM Tissue..
14/8/202322:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:01EDGAR2Form 8-K - Current report
14/8/202322:01GLOBEMiromatrix Reports Second Quarter 2023 Results and Provides..
25/7/202322:01GLOBEMiromatrix to Report Second Quarter 2023 Financial Results
13/7/202322:01GLOBEMiromatrix Poster Voted Best in Congress at the 2023..
01/6/202322:01GLOBEMiromatrix Announces CEO Jeff Ross, Ph.D. will Expand His..
30/5/202322:08GLOBEMiromatrix Presenting at the 2023 American Transplant..
30/5/202322:05GLOBEMiromatrix Announces Participation in the 20th Annual..
11/5/202322:01GLOBEMiromatrix Reports First Quarter 2023 Results and Provides..

Dernières Valeurs Consultées

NASDAQ
MIRO
MiroMatrix Medical
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés